A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jacek Grzybowski Tim Seidler |
| Publication date | July 5, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |